Search
Dianthus Therapeutics Inc
DNTHAdd to Watchlist
82.490USD
+0.600+0.73%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
4.51BMarket Cap
LossP/E TTM
Dianthus Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-06-18The current valuation score of Dianthus Therapeutics Inc is 8.82, ranking 81 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -19.50, which is -121.26% below the recent high of 4.15 and -72.58% above the recent low of -33.66.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.
